- Citations, last 5 years
- 304.4k
- Works, last 5 years
- 38.8k
- h-index
- 1,114
- Scientists listed
- 3 176
- Grants since 2016
- 6 506
Grants received
2024–2029 · career development · K23
A Double Blinded Randomized Feasibility Trial on the Use of Plant Based Omega-3-Fatty Acids (Flaxseed) to Improve Inflammation Driven Pain Outcomes in Children with Sickle Cell Anemia
Chinenye Rebecca Dike · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2028 · research · R01
The role of lysosomal impairment in trichloroethylene induced Parkinsonian neurodegeneration
Briana De Miranda · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2025 · contract · N01
TASK B26: COMPREHENSIVE VIRAL SCREENING PANEL.
Scott James · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2028 · cooperative agreement · U01
Increasing Diversity, Diagnostic Yield, and Efficiency in Clinical Evaluations of Rare Disorders
Bruce R Korf · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · training · T32
CTSA Postdoctoral T32 at the University of Alabama at Birmingham
Bertha Hidalgo · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2026 · research · R21
tRNA-derived short and long RNAs in aging
Anindya Dutta · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · cooperative agreement · U54
CONNECT: Collaborative Network for Nurturing Ecosystems of Common Fund Team Science
Jake Yue Chen · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R01
Tissue-resident NK cell development and function in pregnancy and transplantation: lessons learned from human uterus transplant recipients
Paige M Porrett · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2025 · contract · N01
TASK B26: COMPREHENSIVE VIRAL SCREENING PANEL.
Scott James · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R01
Mechanisms of ciliopathy associated structural birth defects
Bradley K. Yoder · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R35
Mechanistic studies of essential membrane transporters
Hongjin Zheng · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R01
Determining the impact of peer-led community-based PrEP delivery among youth in Brazil: A randomized controlled trial
Katia Bruxvoort · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R01
T cell-intrinsic metabolic control of radiotherapy
Lewis Z. Shi · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R01
Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project)
Warner King Huh · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · career development · K23
Ancestry and sex-related pharmacogenomic and metabolomic signatures of oral anticoagulant response
Brittney H Davis · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R24
A Global Research Resource for Human Tuberculosis
Adrie Jc Steyn · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R35
Integrative Approaches to Study Cell-Type-Specific Protein Dysregulation in Human Diseases
Chen Huang · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R01
Thalamic microglia drive cognitive impairment after cortical injuries
Shinichi Kano · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2026 · research · R21
A Topical Plasmid-based Approach to Cervical Cancer Screening
Jason Morgan Warram · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2027 · research · R01
Role of proteolytic extracellular vesicles in halogen gas dependent chronic lung injury
Kristopher R. Genschmer · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · career development · K23
Use of early time-restricted eating to promote weight loss and improve cardiometabolic health in postpartum women
Camille Schneider Worthington · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2028 · research · R01
The role of lysosomal impairment in trichloroethylene induced Parkinsonian neurodegeneration
Briana De Miranda · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2028 · research · R01
Mechanistic studies of human transporter Sialin
Hongjin Zheng · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R01
The role of orexins in regulating intraocular pressure.
Brian Christopher Samuels · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2026 · research · R21
CRISPR and Humanized mice-based Discovery of a Novel Drug target for HCC Therapy
Narendra Wajapeyee · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R35
Formation, metabolism and cell signaling actions of tryptophan catabolism-derived electrophiles
Dario A Vitturi · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2027 · research · R21
Microbial Biofilms as Regulators of Amphetamine Use Disorders
Angela Michelle Carter · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R01
Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project)
Warner King Huh · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2028 · research · R01
Macrophage-fibroblast interaction is required for asbestos-induced toxicity
A Brent Carter · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · program · P30
UAB Alzheimer's Disease Research Center
Erik D Roberson · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R01
Differentiating slow from rapidly progressive ADPKD by cell-specific mitochondrial and transcriptional profiles
Brittany Nicole Lasseigne · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R01
The resurgence of antibody-drug conjugates via PMPC-polymer engineering
Masakazu Kamata · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · training · T32
CTSA Predoctoral T32 at the University of Alabama at Birmingham
Jennifer S Pollock · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2027 · research · R21
Neutrophil subpopulations and NETosis in HIV-1 pathogenesis
Zdenek Hel · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · career development · K01
An investigation of the long-term impact of in-utero exposure to mild chronic hypertension and antihypertensive therapy on childhood subclinical cardiovascular risk factors
Samantha L Martin · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R01
Role of CXCR3-CXCL10 signaling in T-ALL CNS disease
Ksenia Matlawska-Wasowska · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2028 · career development · K23
Adapting and Piloting a Stress Management Intervention to Reduce Cardiovascular Disease Risk among Women Living with HIV
Jenni M Wise · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2028 · research · R01
Role of DHRS9 in oxylipin metabolism
Natalia Y Kedishvili · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2029 · research · R01
Continuous glucose monitoring for management of type 2 diabetes in pregnancy (CGM2 trial)
Ashley Nicole Battarbee · University of Alabama at Birmingham · funded by National Institutes of Health
2024–2028 · research · R21
The MIGHT Trial - An Exploratory Clinical Trial of IVIG in anti-HMGCR ImmuneMediated Necrotizing Myopathy
James Andrews · University of Alabama at Birmingham · funded by National Institutes of Health
